© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.
Pharmacy Times interviewed Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), on a recent USP survey that showed 9 out of 10 physicians feel their trust in the ability of the US supply chain to deliver safe, quality medicines has eroded.
During the discussion, Piervincenzi addressed how building resilience in the medicine supply chain will help bolster preparedness for what may arise during the COVID-19 pandemic and beyond.
Related Content: